中国麻风皮肤病杂志 ›› 2024, Vol. 40 ›› Issue (3): 196-198.doi: 10.12144/zgmfskin202403196

• 病例报告 • 上一篇    下一篇

阿布昔替尼治疗青斑样血管病一例

叶慧,朱君慧,陈伟锋,张锡宝   

  1. 广州医科大学皮肤病研究所 广州市皮肤病医院，广东广州，510095
  • 出版日期:2024-03-15 发布日期:2024-02-28

Livedoid vasculopathy with abrocitinib: a case report

YE Hui, ZHU Junhui, CHEN Weifeng, ZHANG Xibao   

  1. Institute of Dermatology, Guangzhou Medical University, Guangzhou Dermatology Hospital, Guangzhou 510095, China
  • Online:2024-03-15 Published:2024-02-28

PDF (PC)

121

摘要： 患者，女，31岁。双下肢红斑、丘疹、溃疡伴疼痛2年余，加重3天。临床结合组织病理诊断为青斑样血管病，常规治疗欠佳，给予患者口服阿布昔替尼100 mg每日1次，治疗15周后，红斑、丘疹消退，萎缩性瘢痕及色素沉着减轻，溃疡愈合，疼痛得到控制。

关键词: 阿布昔替尼, 青斑样血管病, 治疗

Abstract: A 31-year-old female presented with erythema, papules and ulcers with pain on the lower extremities for 2 years, aggravated for 3 days. Clinically combined with histopathologic biopsy, she was diagnosed with livedoid vasculopathy and had failed with conventional therapy. The patient was given 100mg oral abrocitinib once a day. After 15 weeks, the erythema and papules subsided, atrophic scar and pigmentatiom reduced, the ulcers healed and the pain was controlled.

Key words: abrocitinib, livedoid vasculopathy, treatment